You've seen the word everywhere — on fitness forums, in longevity podcasts, maybe even at your doctor's office. Here's what they actually are, how they work, and why researchers are paying so much attention to them.
Research context. The peptides covered on this site are sold for research purposes only and are not FDA-approved for human use (with a few noted exceptions). Nothing here is medical advice. Consult a licensed physician before using any compound.
A peptide is a short chain of amino acids — the same building blocks that make up proteins. The difference between a peptide and a protein is basically length: proteins are long chains (think hundreds or thousands of amino acids), peptides are short ones, usually between 2 and 50.
Your body already makes thousands of them. Insulin is a peptide. So is oxytocin. So is the hormone your gut releases after a big meal to tell your brain you're full. Peptides are essentially signaling molecules — short messages your body uses to tell different systems what to do.
The reason researchers are interested in synthetic peptides is that you can design one to send a very specific signal — trigger more growth hormone, accelerate tissue repair, slow fat storage — without the broad systemic effects you'd get from a full hormone or a drug.
Most peptides work by binding to specific receptors on cells — think of it like a key fitting a lock. When the right peptide binds to the right receptor, it triggers a response: release this hormone, activate this repair process, suppress this signal.
What makes peptides interesting from a research standpoint is their specificity. A well-designed peptide can target one receptor type in one tissue without lighting up receptors all over the body. That's harder to achieve with small-molecule drugs, and impossible with broad hormones like testosterone or HGH.
If hormones are like broadcasting a radio signal across the whole city, peptides are more like sending a text message to one specific person. Same information, much more targeted delivery.
They're also generally broken down quickly by the body — most peptides have short half-lives measured in minutes to hours, which is why many research protocols involve daily or weekly administration rather than a single long-acting dose.
No — and this is one of the most common misconceptions. Steroids are synthetic versions of hormones like testosterone or cortisol. They work by flooding your body with an external hormone signal, which produces effects but also suppresses your body's own production and affects many systems at once.
Peptides are structurally completely different. Most of them work by stimulating your body to produce or regulate its own hormones, rather than replacing them. A GH secretagogue peptide like CJC-1295, for example, tells your pituitary to release more growth hormone — it doesn't introduce external GH. Your body's feedback loop stays intact.
That distinction matters a lot in research. It's why compounds like Sermorelin and Tesamorelin have been able to earn FDA approval where synthetic HGH carries more restrictions — the mechanism is fundamentally different.
Most research peptides fall into a handful of broad categories based on what they're studied for:
A few things converged at once. The success of GLP-1 drugs like Ozempic and Wegovy — both peptides — put the whole class on mainstream radar. At the same time, the longevity medicine space exploded, and peptides became a fixture in anti-aging protocols. And the research community has genuinely produced some striking results over the past decade that are finally filtering into public awareness.
There's also a regulatory dimension. In early 2026, the FDA reclassified approximately 14 peptides from Category 2 to Category 1 compounds — a move that signals growing mainstream legitimacy for the space, even as it reshapes how some compounds are sourced and sold.
The short version: peptides aren't new — researchers have been studying them for decades — but they've finally crossed over from niche biohacker territory into broader public conversation.
Two peptides most people have already heard of: insulin (used to treat diabetes since the 1920s) and Ozempic/semaglutide (the GLP-1 weight loss drug that's been all over the news). Both are peptides. The category isn't as exotic as it sounds.
Pharmaceutical peptides like insulin, Ozempic, and Vyleesi have gone through the full FDA approval process — years of clinical trials establishing safety and efficacy for specific indications. They're prescribed by doctors and dispensed by pharmacies.
Research peptides are compounds that have been studied — sometimes extensively — but haven't completed the FDA approval pathway for human use. They're legally sold for laboratory research purposes. Some have significant published data behind them. Others are earlier stage.
The compounds covered on this site fall into that second category, with the exception of PT-141 and Tesamorelin which do have FDA approvals. All are sourced from vendors who provide Certificates of Analysis confirming purity and identity.
If you're new to the space, the best next step is picking the research area you're most interested in and reading up on the specific compounds in that category. The database covers 34 peptides across fat loss, recovery, longevity, and cognitive research — each with mechanism breakdowns, protocol data, and verified vendor pricing.
Browse all 34 peptides with mechanism breakdowns, dosage protocols, and COA-verified pricing from 3 vendors.
Browse the Full Database → New? Start Here